Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TELA
|
Megan Smeykal
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 93 Reduced 0.76% |
$1,082
$11.63 p/Share
|
Mar 31
2022 |
|
CMTV
|
Jacques R Couture |
BUY
Open market or private purchase
|
Direct | 250 Added 0.7% |
$5,688
$22.75 p/Share
|
Mar 31
2022 |
|
EVLO
|
David R Epstein
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,926 Added 7.36% |
-
|
Mar 31
2022 |
|
ATHA
|
Kelly A Romano |
BUY
Open market or private purchase
|
Direct | 8,000 Added 49.03% |
$104,880
$13.11 p/Share
|
Mar 31
2022 |
|
EPSN
|
David W Winn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,500 Added 32.61% |
$48,375
$6.45 p/Share
|
Mar 31
2022 |
|
EPZM
|
Kevin T Conroy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 13,043 Added 23.22% |
$14,999
$1.15 p/Share
|
Mar 31
2022 |
|
EPZM
|
David M Mott
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,653 Added 9.39% |
$23,751
$1.15 p/Share
|
Mar 31
2022 |
|
EPZM
|
Beveridge, Roy A
Director |
BUY
Grant, award, or other acquisition
|
Direct | 11,413 Added 28.87% |
$13,125
$1.15 p/Share
|
Mar 31
2022 |
|
FNCB
|
Keith W. Eckel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26 Added 0.16% |
$249
$9.59 p/Share
|
Mar 31
2022 |
|
INSE
|
Andrew C Stone
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,350 Reduced 18.26% |
$28,905
$12.3 p/Share
|
Mar 31
2022 |
|
INSE
|
Andrew C Stone
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 27.98% |
-
|
Mar 31
2022 |
|
CVLY
|
John W Giambalvo
Director |
BUY
Open market or private purchase
|
Direct | 263 Added 0.84% |
$5,852
$22.25 p/Share
|
Mar 31
2022 |
|
CPSS
|
John Patrick Harton
Sr. Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 25,000 Added 11.71% |
$39,250
$1.57 p/Share
|
Mar 31
2022 |
|
SWKH
|
Marcus Edward Pennington
Director |
BUY
Grant, award, or other acquisition
|
Direct | 916 Added 15.51% |
-
|
Mar 31
2022 |
|
SWKH
|
Robert K. Hatcher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 925 Added 36.29% |
-
|
Mar 31
2022 |
|
SWKH
|
Robert K. Hatcher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 699 Added 50.0% |
-
|
Mar 31
2022 |
|
VFF
|
Michael A Degiglio
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 90,000 Reduced 0.96% |
$478,800
$5.32 p/Share
|
Mar 31
2022 |
|
TRUE
|
Michael Darrow
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,521 Reduced 0.24% |
$9,454
$3.75 p/Share
|
Mar 31
2022 |
|
TRUE
|
Michael Darrow
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 265,083 Added 19.86% |
-
|
Mar 31
2022 |
|
TRUE
|
Jantoon Reigersman
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 256,000 Added 31.74% |
-
|
Mar 31
2022 |
|
TRUE
|
Jeff Swart
EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,789 Reduced 0.51% |
$6,709
$3.75 p/Share
|
Mar 31
2022 |
|
TRUE
|
Jeff Swart
EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 94,699 Added 21.36% |
-
|
Mar 31
2022 |
|
DOMA
|
Noaman Ahmad
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 427,350 Added 25.02% |
-
|
Mar 31
2022 |
|
DOMA
|
Hasan Rizvi
President of Technology & Ops. |
BUY
Grant, award, or other acquisition
|
Direct | 641,025 Added 34.07% |
-
|
Mar 31
2022 |
|
DOMA
|
Michael Alan Smith
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 181,623 Added 35.79% |
-
|
Mar 31
2022 |
|
DOMA
|
Eric J Watson
General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 160,256 Added 26.88% |
-
|
Mar 31
2022 |
|
ZEUS
|
Michael D Siegal
Executive Chairman of Board |
SELL
Bona fide gift
|
Direct | 15,000 Reduced 1.22% |
-
|
Mar 31
2022 |
|
HDSN
|
Richard Parrillo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 8,396 Reduced 3.51% |
$51,803
$6.17 p/Share
|
Mar 31
2022 |
|
HDSN
|
Richard Parrillo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 81,300 Added 26.02% |
$94,308
$1.16 p/Share
|
Mar 31
2022 |
|
OIS
|
Robert L Potter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,799 Added 2.53% |
$12,503
$6.95 p/Share
|
Mar 31
2022 |
|
CVEO
|
Richard A Navarre
Director |
BUY
Grant, award, or other acquisition
|
Direct | 397 Added 1.05% |
-
|
Mar 31
2022 |
|
GCI
|
John Jeffry Louis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,543 Added 1.57% |
$24,999
$4.51 p/Share
|
Mar 31
2022 |
|
MPB
|
Matthew G De Soto
Director |
BUY
Open market or private purchase
|
Direct | 280 Added 0.64% |
$7,507
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Gregory M Kerwin
Director |
BUY
Open market or private purchase
|
Direct | 37 Added 0.1% |
$992
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Theodore W Mowery
Director |
BUY
Open market or private purchase
|
Direct | 74 Added 0.38% |
$1,984
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Noble C Quandel Jr
Director |
BUY
Open market or private purchase
|
Direct | 112 Added 0.14% |
$3,003
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Robert C Grubic
Director |
BUY
Open market or private purchase
|
Direct | 186 Added 0.34% |
$4,987
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Robert A Abel
Director |
BUY
Open market or private purchase
|
Direct | 18 Added 0.81% |
$483
$26.81 p/Share
|
Mar 31
2022 |
|
MPB
|
Kimberly J Brumbaugh
Director |
BUY
Open market or private purchase
|
Direct | 93 Added 3.36% |
$2,493
$26.81 p/Share
|
Mar 31
2022 |
|
SRGA
|
William Scott Durall
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,676 Reduced 0.42% |
$1,103
$0.3 p/Share
|
Mar 31
2022 |
|
BWB
|
Douglas J. Parish |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 3.74% |
-
|
Mar 31
2022 |
|
BWB
|
David B. Juran |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 0.05% |
-
|
Mar 31
2022 |
|
BWB
|
James S. Johnson |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 1.0% |
-
|
Mar 31
2022 |
|
BWB
|
Lisa Brezonik |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 5.75% |
-
|
Mar 31
2022 |
|
BWB
|
Mohammed Lawal |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 4.06% |
-
|
Mar 31
2022 |
|
BWB
|
Todd B. Urness |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 0.05% |
-
|
Mar 31
2022 |
|
BWB
|
Thomas P. Trutna |
BUY
Grant, award, or other acquisition
|
Direct | 582 Added 0.31% |
-
|
Mar 31
2022 |
|
REPX
|
Philip A Riley
CFO & EVP STRATEGY |
BUY
Open market or private purchase
|
Direct | 500 Added 1.1% |
$12,250
$24.5 p/Share
|
Mar 31
2022 |
|
GERN
|
Robert J. Spiegel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,284 Added 3.61% |
-
|
Mar 31
2022 |
|
MSBI
|
Jeffrey G. Ludwig
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 1,382 Added 0.59% |
$35,365
$25.59 p/Share
|
Mar 31
2022 |